Supply high quality Clopidogrel powder CAS NO.113665-84-2

Competive advantages

1.Rich experience

We specialize in this filed for many years,our steriods and hormones exported to all over the world and established long friendly relations of coroperation with them.

2.Great quality,purity and favorable

Good quality is one of our biggest secert to success;u can get the best quality and service from us.

3.Safest and fastest delivery

We have adequate stock so that we can deliver the products with 24 hours as soon as receiving the payment.Fast and discreet shipment will be arranged to pass customs.

4.Good package

Unique ways to ship 10g to 100kg powders to your destination.We offer melting powder into liquid service and ship the liquid in special bottles.

5.Great after-sales service

Any questions or problems after receiving the product,pls feel free to contact us.Problems would be solved immediately.

General Comments:

We have professional team for package and shipment.Unique ways to ship 10g to 100kg powders at one time to your country.Our shipments are by EMS,DHL,TNT,FEDEX,HKEMS,UPS,etc for 25kg,between 25kg-200kg by air,over 200kg by sea.Fast and secure shipment could be arranged for customs pass guaranteed.

Our company has independent import and export authority,also has the certificate of importing and exporting pharmaceutical materials.At the same time we are developed manufactures with mass stock.

Clopidogrel is used to prevent myocardial infarction (heart attack) and stroke in people who are at high risk of these events, including those with a history of myocardial infarction and other forms of acute coronary syndrome, stroke, and those with peripheral artery disease.

Treatment with clopidogrel or a related drug is recommended by the American Heart Association and the American College of Cardiology for people who:

• Present for treatment with a myocardial infarction with ST-elevation including

• A loading dose given in advance of percutaneous coronary intervention (PCI), followed by a full year of treatment for those receiving a vascular stent
• A loading dose given in advance of fibrinolytic therapy, continued for at least 14 days

• Present for treatment of a non-ST elevation myocardial infarction or unstable angina

• Including a loading dose and maintenance therapy in those receiving PCI and unable to tolerate aspirin therapy
• Maintenance therapy for up to 12 months in those at medium to high risk for which a noninvasive treatment strategy is chosen

• In those with stable ischemic heart disease, treatment with clopidogrel is described as a "reasonable" option for monotherapy in those who cannot tolerate aspirin, as is treatment with clopidogrel in combination with aspirin in certain high risk patients.

It is also used, along with acetylsalicylic acid (ASA, aspirin), for the prevention of thrombosis after placement of an coronary stent or as an alternative antiplatelet drug for people intolerant to aspirin.